✦ LIBER ✦

Exam 2: Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of the Protease Inhibitor BI 20

✍ Stefan Zeuzem; Tarik Asselah; Peter Angus; Jean–Pierre Zarski; Dominique Larrey; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 915 KB

Potency, safety, and pharmacokinetics of

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

101 SVR4 AND SVR12 WITH AN INTERFERON-FR

✍ S. Zeuzem; V. Soriano; T. Asselah; J.-P. Bronowicki; A. Lohse; B. Müllhaupt; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 158 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

2007 4 WEEK THERAPY WITH THE NON-NUCLEOS

✍ Larrey, D.; Lohse, A.; de Ledinghen, V.; Trepo, C.; Gerlach, T.; Zarski, J.-P.; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

1420 THE EFFICACY AND SAFETY OF THE INTE

✍ Soriano, V.; Gane, E.; Angus, P.; Stickel, F.; Bronowicki, J.-P.; Roberts, S.; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB